Lupin gets USFDA nod for diabetes drug
   
Quotes

Lupin gets USFDA nod for diabetes drug

Last Updated: Monday, July 22, 2013, 17:03
 
 Comment 0
 
Lupin gets USFDA nod for diabetes drug
New Delhi: Drug major Lupin Monday said it has received US health regulator's approval to sell its generic version of Glumetza HCl ER Tablets, a diabetes drug, in the American market.

The company's US-based subsidiary Lupin Pharmaceuticals Inc has received final approval from US Food and Drug Administration (USFDA) for its Metformin Hydrochloride extended release tablets in strengths of 500 mg and 1000 mg, Lupin Ltd said in a statement.

"Lupin believes that it is the first applicant to file an abbreviated new drug application (ANDA) for Glumetza HCl ER Tablets of 500 mg and 1000 mg strengths, and as such will be entitled to 180 days of marketing exclusivity," it added.

Metformin HCl ER tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

As per IMS Health data, Glumetza HCl ER tablets of 500 mg and 1000 mg had sales of nearly USD 144 million in the US market in 2012-13.

Shares of Lupin today closed at Rs 890.50 apiece on the BSE, down 0.92 percent from their previous close.

PTI



First Published: Monday, July 22, 2013, 17:03


Comments


comments powered by Disqus
Mahindra New Thar CRDe
Mahindra New Thar CRDe
New Generation Scorpio
New Generation Scorpio
BRICS SUMMIT Ufa
BRICS SUMMIT Ufa
New Vento 2015
New Vento 2015
Audi all-new SUV Q3
Audi all-new SUV Q3

Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved